Open AccessAssessment of the feed additive consisting of Lactococcus lactis NCIMB 30160 for all animal species for the renewal of its authorisation (Lactosan GmbH & Co KG)
Author(s) -
Bampidis Vasileios,
Azimonti Giovanna,
Bastos Maria de Lourdes,
Christensen Henrik,
Dusemund Birgit,
Fašmon Durjava Mojca,
Kouba Maryline,
LópezAlonso Marta,
López Puente Secundino,
Marcon Francesca,
Mayo Baltasar,
Pechová Alena,
Petkova Mariana,
Ramos Fernando,
Sanz Yolanda,
Villa Roberto Edoardo,
Woutersen Ruud,
Galobart Jaume,
Gregoretti Lucilla,
Revez Joana,
Vettori Maria Vittoria,
Brozzi Rosella
Publication year - 2022
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2022.6975
Subject(s) - authorization , context (archaeology) , lactococcus lactis , european commission , microbiology and biotechnology , feed additive , animal feed , biology , food science , business , european union , lactic acid , computer science , bacteria , computer security , paleontology , genetics , broiler , economic policy
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of Lactococcus lactis NCIMB 30160 as a technological additive for all animal species. The additive aims to improve the production of silage and is authorised for all animal species. The applicant provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There was no new evidence to lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concluded that the additive remains safe for all animal species, consumers and the environment under the authorised conditions of use. Regarding user safety, Lactococcus lactis NCIMB 30160 is not irritant to skin and eyes but is considered a skin and respiratory sensitiser. There was no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.